Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 56,000 shares at $76.00 ($4.3M) on 2019-04-23, disclosed to the SEC on 2019-04-24.
Scheduled sale ($4.3M) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABT | SELL | 2018-02-21 | $3.9M | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.2M | — | Filing → |
| ABT | SELL | 2018-02-21 | $331K | — | Filing → |